PageOverview.com
 

Domains targeting keyword clotting

Keyword clotting was used in the provided list of websites.

 
Number of websites/domains displayed: 12
Results found: 12
 

Websites discovered:

blood disorders & blood diseases solutions Natural solutions for blood,blood clotting disorders,blood disorders,blood diseases,blood thinner,blood clot medication,natural ways blood,threat of blood,treatment for blood ,blood thinners,symptoms of blood -southof64.com
http://pageoverview.com/website-report/southof64.com
southof64-Natural solutions for blood,blood clotting disorders,blood disorders,blood diseases,blood thinner,blood clot medication,natural ways blood,threat of blood,treatment for blood ,blood thinners,symptoms of blood
  • Expected expiration: September 8th in 2018
  • Creation date: September 8th in 2009
  • Renew date: October 5th in 2017
  • Adsense ID: pub-2929033336496227
Thrombosis and Hemostasis Societies of North America (THSNA)
http://pageoverview.com/website-report/thsna.org
THSNA the Societies is a federation of 10 of the leading non-profit organizations in hemostasis and thrombosis in the U.S. and Canada. With the continuity between Summits provided by the new federation, we now have the opportunity to realize our vision of the Summit becoming the premier forum for hemostasis and thrombosis in North America.
    Thrombocytes (Platelets) - 8 Essential Facts To Know | Thrombocytes
    http://pageoverview.com/website-report/thrombocyte.com
    Thrombocyte. A disclike cytoplasmic blood component that plays a key role in blood clotting. Below are eight vital facts about thrombocytes.
    • Expected expiration: May 28th in 2019
    • Creation date: May 28th in 2010
    • Renew date: November 29th in 2016
    • Google Analytics: 42618665-8
    • Adsense ID: pub-3209795793760981
    Nataonline
    http://pageoverview.com/website-report/nataonline.com
    Education In Transfusion Medicine And Clinical Use Of Transfusion Alternatives
    • Expected expiration: March 7th in 2022
    • Creation date: March 7th in 2001
    • Renew date: December 30th in 2016
    • Google Analytics: 2081177-1
    Haematologic Technologies | Haematologic Technologies, Inc.
    http://pageoverview.com/website-report/haemtech.com
    Haematologic Technologies is a manufacturer of highly-purified coagulation proteins, antibodies and associated reagents.
    • Expected expiration: October 22nd in 2018
    • Creation date: October 23rd in 1997
    • Renew date: August 3rd in 2016
    • Google Analytics: 7793128-2
    Natural Blood Thinners and Blood Clotting Facts
    http://pageoverview.com/website-report/naturalbloodthinners.org
    Those with high levels of cholesterol in blood can also benefit from the use of natural blood thinners to prevent coronary blood clot symptoms or blood clot
    • Expected expiration: June 25th in 2018
    • Creation date: June 25th in 2013
    • Renew date: April 25th in 2016
    • Adsense ID: pub-8615561501678895
    • Google Analytics: 42865383-4
    • Google Plus Account: +NaturalbloodthinnersOrg
    Hemophilia A Treatment | HEMLIBRA® (emicizumab-kxwh)
    http://pageoverview.com/website-report/hemlibra.com
    Learn about HEMLIBRA® (emicizumab-kxwh), a hemophilia A treatment now approved for people with hemophilia A with factor VIII inhibitors. See BOXED WARNING. What is HEMLIBRA? HEMLIBRA is a prescription medicine used for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children with hemophilia A with factor VIII inhibitors. What is the most important information I should know about HEMLIBRA? HEMLIBRA increases the potential for your blood to clot. Discontinue prophylactic use of bypassing agents the day before starting HEMLIBRA prophylaxis. Carefully follow your healthcare provider’s instructions regarding when to use an on-demand bypassing agent, and the dose and schedule you should use. HEMLIBRA may cause the following serious side effects when used with aPCC (FEIBA®), including: Thrombotic microangiopathy (TMA). This is a condition involving blood clots and injury to small blood vessels that may cause harm to your kidneys, brain, and other organs. Get medical help right away if you have any of the signs and symptoms of TMA during or after treatment with HEMLIBRA. Blood clots (thrombotic events). Blood clots may form in blood vessels in your arm, leg, lung or head. Get medical help right away if you have any of the signs or symptoms of blood clots during or after treatment with HEMLIBRA. If aPCC (FEIBA®) is needed, talk to your healthcare provider in case you feel you need more than 100 U/kg of aPCC (FEIBA®) total. How should I use Hemlibra? See the detailed “Instructions for Use” that comes with your HEMLIBRA for information on how to prepare and inject a dose of HEMLIBRA, and how to properly throw away (dispose of) used needles and syringes. HEMLIBRA may interfere with laboratory tests that measure how well your blood is clotting and may cause a false reading. Talk to your healthcare provider about how this may affect your care. What are the other possible side effects of HEMLIBRA? The most common side effects of HEMLIBRA include: redness, tenderness, warmth, or itching at the site of injection; headache; and joint pain. These are not all of the possible side effects of HEMLIBRA. You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at (888) 835-2555. Please see the HEMLIBRA full Prescribing Information and Medication Guide for more important safety information including Serious Side Effects.
    • Expected expiration: June 3rd in 2019
    • Creation date: June 3rd in 2015
    • Renew date: August 31st in 2017
    Bleeding & Clotting Disorders Institute | Peoria, Illinois
    http://pageoverview.com/website-report/ilbcdi.org
    BCDI in Peoria, Illinois offers coordinated, family-centered care for persons with congenital or chronic clotting and bleeding disorders.
    • Expected expiration: March 26th in 2019
    • Creation date: March 26th in 2010
    • Renew date: June 4th in 2015
    • Google Analytics: 42864853-1
    Welcome!
    http://pageoverview.com/website-report/brodabarnes.org
    Medical Education, Broda Barnes, non profit,thyroid, endocrine,Adrenals, Cortisol,Endocrinology
    • Expected expiration: November 6th in 2018
    • Creation date: November 7th in 1997
    • Renew date: November 11th in 2013
    Trombofilik | Pro bezpečnější život s trombofilií
    http://pageoverview.com/website-report/thrombophiliac.com
    Who is thrombophiliac? Thrombophiliac is a person who has an innate genetically conditioned tendency to increased blood clotting and a tendency to an increased formation of thrombosis - this is called thrombophilia. The diagnosis of thrombophilia by itself does not mean anything, but it may be a risk factor | Trombofilik
    • Expected expiration: March 31st in 2018
    • Creation date: March 31st in 2016
    • Renew date: October 8th in 2017
    • Google Analytics: 107424874-1
    • Adsense ID: pub-1144325370802511
    The Plasma Proteome Institute
    http://pageoverview.com/website-report/plasmaproteome.org
    • Expected expiration: July 8th in 2018
    • Creation date: July 8th in 2002
    • Renew date: June 29th in 2017
    Hemostatic Agents, Clotting Powder & Wound Dressings | Celox Celox
    http://pageoverview.com/website-report/celoxmedical.com
    Celox is a range of hemostats to control moderate to severe traumatic bleeding - proven technology, applied in military medicine and by emergency services.
    • Expected expiration: February 8th in 2018
    • Creation date: February 8th in 2006
    • Renew date: February 9th in 2017
    • Google Analytics: 2815075-1
    0.0125 // 2024-06-15 06:04:10
    All Rights reserved 2018 © PageOverview.com